These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26621801)

  • 21. Epitope peptides and immunotherapy.
    Tanabe S
    Curr Protein Pept Sci; 2007 Feb; 8(1):109-18. PubMed ID: 17305564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intranasal treatment with a recombinant hypoallergenic derivative of the major birch pollen allergen Bet v 1 prevents allergic sensitization and airway inflammation in mice.
    Wiedermann U; Herz U; Baier K; Vrtala S; Neuhaus-Steinmetz U; Bohle B; Dekan G; Renz H; Ebner C; Valenta R; Kraft D
    Int Arch Allergy Immunol; 2001 Sep; 126(1):68-77. PubMed ID: 11641608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of specific immune responses by chemical and structural modifications of allergens.
    Akdis CA; Blaser K
    Int Arch Allergy Immunol; 2000 Apr; 121(4):261-9. PubMed ID: 10828716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reducing allergenicity by altering allergen fold: a mosaic protein of Phl p 1 for allergy vaccination.
    Ball T; Linhart B; Sonneck K; Blatt K; Herrmann H; Valent P; Stoecklinger A; Lupinek C; Thalhamer J; Fedorov AA; Almo SC; Valenta R
    Allergy; 2009 Apr; 64(4):569-80. PubMed ID: 19243361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral administration of recombinant Lactococcus lactis expressing bovine beta-lactoglobulin partially prevents mice from sensitization.
    Adel-Patient K; Ah-Leung S; Creminon C; Nouaille S; Chatel JM; Langella P; Wal JM
    Clin Exp Allergy; 2005 Apr; 35(4):539-46. PubMed ID: 15836765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A protective allergy vaccine based on CpG- and protamine-containing PLGA microparticles.
    Martínez Gómez JM; Fischer S; Csaba N; Kündig TM; Merkle HP; Gander B; Johansen P
    Pharm Res; 2007 Oct; 24(10):1927-35. PubMed ID: 17541735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of peanut-induced allergic immune responses by oral lactic acid bacteria-based vaccines in mice.
    Ren C; Zhang Q; Wang G; Ai C; Hu M; Liu X; Tian F; Zhao J; Chen Y; Wang M; Zhang H; Chen W
    Appl Microbiol Biotechnol; 2014; 98(14):6353-64. PubMed ID: 24770368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunotherapy with oligomannose-coated liposomes ameliorates allergic symptoms in a murine food allergy model.
    Kawakita A; Shirasaki H; Yasutomi M; Tokuriki S; Mayumi M; Naiki H; Ohshima Y
    Allergy; 2012 Mar; 67(3):371-9. PubMed ID: 22423374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A recombinant hypoallergenic parvalbumin mutant for immunotherapy of IgE-mediated fish allergy.
    Swoboda I; Bugajska-Schretter A; Linhart B; Verdino P; Keller W; Schulmeister U; Sperr WR; Valent P; Peltre G; Quirce S; Douladiris N; Papadopoulos NG; Valenta R; Spitzauer S
    J Immunol; 2007 May; 178(10):6290-6. PubMed ID: 17475857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The recombinant major allergen of Parietaria judaica and its hypoallergenic variant: in vivo evaluation in a murine model of allergic sensitization.
    Orlandi A; Grasso F; Corinti S; Marinaro M; Bonura A; Boirivant M; Colombo P; Di Felice G
    Clin Exp Allergy; 2004 Mar; 34(3):470-7. PubMed ID: 15005743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allergen-related approaches to immunotherapy.
    Rolland JM; Gardner LM; O'Hehir RE
    Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A hypoallergenic variant of Der p 1 as a candidate for mite allergy vaccines.
    Walgraffe D; Mattéotti C; El Bakkoury M; Garcia L; Marchand C; Bullens D; Vandenbranden M; Jacquet A
    J Allergy Clin Immunol; 2009 May; 123(5):1150-6. PubMed ID: 19152967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disruption of allergenic activity of the major grass pollen allergen Phl p 2 by reassembly as a mosaic protein.
    Mothes-Luksch N; Stumvoll S; Linhart B; Focke M; Krauth MT; Hauswirth A; Valent P; Verdino P; Pavkov T; Keller W; Grote M; Valenta R
    J Immunol; 2008 Oct; 181(7):4864-73. PubMed ID: 18802090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral immunotherapy with immunodominant T-cell epitope peptides alleviates allergic reactions in a Balb/c mouse model of egg allergy.
    Rupa P; Mine Y
    Allergy; 2012 Jan; 67(1):74-82. PubMed ID: 21950267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-Dose Allergen-Specific Immunotherapy Induces Tolerance in a Murine Model of Shrimp Allergy.
    Leung NYH; Wai CYY; Shu SA; Chang CC; Chu KH; Leung PSC
    Int Arch Allergy Immunol; 2017; 174(2):86-96. PubMed ID: 29065408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant interleukin 6 with M cell-targeting moiety produced in Lactococcus lactis IL1403 as a potent mucosal adjuvant for peroral immunization.
    Li HS; Piao DC; Jiang T; Bok JD; Cho CS; Lee YS; Kang SK; Choi YJ
    Vaccine; 2015 Apr; 33(16):1959-67. PubMed ID: 25738814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineered recombinant ovomucoid third domain can modulate allergenic response in Balb/c mice model.
    Rupa P; Mine Y
    Biochem Biophys Res Commun; 2006 Apr; 342(3):710-7. PubMed ID: 16494843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antagonistic peptides specifically inhibit proliferation, cytokine production, CD40L expression, and help for IgE synthesis by Der p 1-specific human T-cell clones.
    Fasler S; Aversa G; de Vries JE; Yssel H
    J Allergy Clin Immunol; 1998 Apr; 101(4 Pt 1):521-30. PubMed ID: 9564806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of a hybrid protein designed with segments of allergens from Blomia tropicalis and Dermatophagoides pteronyssinus.
    Martínez D; Cantillo JF; Herazo H; Wortmann J; Keller W; Caraballo L; Puerta L
    Immunol Lett; 2018 Apr; 196():103-112. PubMed ID: 29408409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation.
    Möbs C; Slotosch C; Löffler H; Jakob T; Hertl M; Pfützner W
    J Immunol; 2010 Feb; 184(4):2194-203. PubMed ID: 20048125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.